Cargando…

Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancer

The development of targeted therapies that inhibit cancer-driving oncogenes has improved outcomes of patients diagnosed with lung adenocarcinoma (LUAD). In contrast, patients diagnosed with lung squamous cell carcinoma (LUSC) suffer worse survival outcomes and lack effective targeted treatment optio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bollig-Fischer, Aliccia, Bao, Bin, Manning, Morenci, Dyson, Greg, Michelhaugh, Sharon K., Mittal, Sandeep, Bepler, Gerold, Mamdani, Hirva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607376/ https://www.ncbi.nlm.nih.gov/pubmed/35006496 http://dx.doi.org/10.1186/s43556-021-00051-2

Ejemplares similares

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics
por: Bollig-Fischer, Aliccia, et al.
Publicado: (2015)

Fibroblast Growth Factor Receptor 1 Amplification in Non-Small Cell Lung Cancer by Quantitative Real-Time PCR
por: Gadgeel, Shirish M., et al.
Publicado: (2013)

Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer
por: Ayodeji, Saheed A., et al.
Publicado: (2023)

Slitrk Missense Mutations Associated with Neuropsychiatric Disorders Distinctively Impair Slitrk Trafficking and Synapse Formation
por: Kang, Hyeyeon, et al.
Publicado: (2016)

Obesity‐induced MBD2_v2 expression promotes tumor‐initiating triple‐negative breast cancer stem cells
por: Teslow, Emily A., et al.
Publicado: (2019)

Oncogene Activation Induces Metabolic Transformation Resulting in Insulin-Independence in Human Breast Cancer Cells
por: Bollig-Fischer, Aliccia, et al.
Publicado: (2011)

Porcine SLITRK1: Molecular cloning and characterization
por: Larsen, Knud, et al.
Publicado: (2014)

Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity
por: Bao, Bin, et al.
Publicado: (2017)

3D models of glioblastoma interaction with cortical cells
por: Abedin, Md Joynal, et al.
Publicado: (2023)

Characterization of SLITRK1 Variation in Obsessive-Compulsive Disorder
por: Ozomaro, Uzoezi, et al.
Publicado: (2013)

Slitrk1 is localized to excitatory synapses and promotes their development
por: Beaubien, François, et al.
Publicado: (2016)

The Role of SliTrk5 in Central Nervous System
por: Liu, Yan, et al.
Publicado: (2022)

Exogenous IL‐6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild‐type, African American PCa cells
por: Teslow, Emily A., et al.
Publicado: (2018)

Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1
por: Michelhaugh, Sharon K, et al.
Publicado: (2015)

Selective control of inhibitory synapse development by Slitrk3-PTPδ trans-synaptic interaction
por: Takahashi, Hideto, et al.
Publicado: (2012)

A Conserved Tyrosine Residue in Slitrk3 Carboxyl-Terminus Is Critical for GABAergic Synapse Development
por: Li, Jun, et al.
Publicado: (2019)

Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer
por: Mamdani, Hirva, et al.
Publicado: (2017)

Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
por: Mamdani, Hirva, et al.
Publicado: (2020)

SLITRK5 is a negative regulator of hedgehog signaling in osteoblasts
por: Sun, Jun, et al.
Publicado: (2021)

SLITRK1-mediated noradrenergic projection suppression in the neonatal prefrontal cortex
por: Hatayama, Minoru, et al.
Publicado: (2022)

Pan-cancer analysis of RNA methyltransferases identifies FTSJ3 as a potential regulator of breast cancer progression
por: Manning, Morenci, et al.
Publicado: (2020)

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
por: Ahmad, Aamir, et al.
Publicado: (2015)

Impaired Auditory-Vestibular Functions and Behavioral Abnormalities of Slitrk6-Deficient Mice
por: Matsumoto, Yoshifumi, et al.
Publicado: (2011)

Disorganized Innervation and Neuronal Loss in the Inner Ear of Slitrk6-Deficient Mice
por: Katayama, Kei-ichi, et al.
Publicado: (2009)

Rare Synaptogenesis-Impairing Mutations in SLITRK5 Are Associated with Obsessive Compulsive Disorder
por: Song, Minseok, et al.
Publicado: (2017)

Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation
por: Katayama, Kei-ichi, et al.
Publicado: (2022)

A Method for Biomarker Directed Survival Prediction in Advanced Non-Small-Cell Lung Cancer Patients Treated with Carboplatin-Based Therapy
por: Chen, Wei, et al.
Publicado: (2013)

The Predominant Proteins that React to the MC-20 Estrogen Receptor Alpha Antibody Differ in Molecular Weight between the Mammary Gland and Uterus in the Mouse and Rat
por: Bollig-Fischer, Aliccia, et al.
Publicado: (2012)

(–)–Epicatechin combined with 8 weeks of treadmill exercise is associated with increased angiogenic and mitochondrial signaling in mice
por: Lee, Icksoo, et al.
Publicado: (2015)

Identifying patients with NTRK fusion cancer
por: Solomon, J P, et al.
Publicado: (2019)

A review of NTRK fusions in cancer
por: Manea, Cristina Alexandra, et al.
Publicado: (2022)

Detecting qualitative changes in biological systems
por: Mitrea, Cristina, et al.
Publicado: (2020)

Slitrk2 controls excitatory synapse development via PDZ-mediated protein interactions
por: Han, Kyung Ah, et al.
Publicado: (2019)

Identification of SLITRK6 as a Novel Biomarker in hepatocellular carcinoma by comprehensive bioinformatic analysis
por: Liu, Xudong, et al.
Publicado: (2021)

Developmental control of noradrenergic system by SLITRK1 and its implications in the pathophysiology of neuropsychiatric disorders
por: Hatayama, Minoru, et al.
Publicado: (2023)

Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
por: Liu, Gang, et al.
Publicado: (2009)

Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice
por: Thakur, Archana, et al.
Publicado: (2008)

Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition
por: Azmi, Asfar S., et al.
Publicado: (2015)

Immunotherapy in Lung Cancer: Current Landscape and Future Directions
por: Mamdani, Hirva, et al.
Publicado: (2022)

In Silico Analysis Identified Putative Pathogenic Missense nsSNPs in Human SLITRK1 Gene
por: Ali, Muhammad Zeeshan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2tfn9ouh6slavibslfo7l94jfg